JP2016516805A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516805A5
JP2016516805A5 JP2016508263A JP2016508263A JP2016516805A5 JP 2016516805 A5 JP2016516805 A5 JP 2016516805A5 JP 2016508263 A JP2016508263 A JP 2016508263A JP 2016508263 A JP2016508263 A JP 2016508263A JP 2016516805 A5 JP2016516805 A5 JP 2016516805A5
Authority
JP
Japan
Prior art keywords
oxo
pyrido
oxazolidine
ethyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016508263A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516805A (ja
JP6375365B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/060724 external-priority patent/WO2014170821A1/en
Publication of JP2016516805A publication Critical patent/JP2016516805A/ja
Publication of JP2016516805A5 publication Critical patent/JP2016516805A5/ja
Application granted granted Critical
Publication of JP6375365B2 publication Critical patent/JP6375365B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016508263A 2013-04-16 2014-04-15 抗菌活性を有する二芳香族誘導体 Expired - Fee Related JP6375365B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2013053021 2013-04-16
IBPCT/IB2013/053021 2013-04-16
PCT/IB2014/060724 WO2014170821A1 (en) 2013-04-16 2014-04-15 Antibacterial biaromatic derivatives

Publications (3)

Publication Number Publication Date
JP2016516805A JP2016516805A (ja) 2016-06-09
JP2016516805A5 true JP2016516805A5 (cg-RX-API-DMAC7.html) 2017-06-01
JP6375365B2 JP6375365B2 (ja) 2018-08-15

Family

ID=50639826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016508263A Expired - Fee Related JP6375365B2 (ja) 2013-04-16 2014-04-15 抗菌活性を有する二芳香族誘導体

Country Status (21)

Country Link
US (1) US9527867B2 (cg-RX-API-DMAC7.html)
EP (1) EP2986607B1 (cg-RX-API-DMAC7.html)
JP (1) JP6375365B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150143720A (cg-RX-API-DMAC7.html)
CN (1) CN105143216B (cg-RX-API-DMAC7.html)
AR (1) AR095884A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014255326B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015026261A8 (cg-RX-API-DMAC7.html)
CA (1) CA2907832A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015003019A1 (cg-RX-API-DMAC7.html)
EA (1) EA029361B1 (cg-RX-API-DMAC7.html)
ES (1) ES2640482T3 (cg-RX-API-DMAC7.html)
HK (1) HK1221459A1 (cg-RX-API-DMAC7.html)
MA (1) MA38588B1 (cg-RX-API-DMAC7.html)
MX (1) MX362338B (cg-RX-API-DMAC7.html)
PH (1) PH12015502411A1 (cg-RX-API-DMAC7.html)
PL (1) PL2986607T3 (cg-RX-API-DMAC7.html)
SA (1) SA515361261B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201508479RA (cg-RX-API-DMAC7.html)
TW (1) TWI631119B (cg-RX-API-DMAC7.html)
WO (1) WO2014170821A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR073774A1 (es) 2008-10-07 2010-12-01 Actelion Pharmaceuticals Ltd Compuestos antibioticos oxazolidinona triciclicos
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
EP3429997A1 (de) 2016-03-16 2019-01-23 Bayer CropScience Aktiengesellschaft N-(cyanbenzyl)-6-(cyclopropylcarbonylamino)-4-(phenyl)-pyridin-2-carboxamid-derivate und verwandte verbindungen als pestizide pflanzenschutzmittel
AR108108A1 (es) 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
GB2550437B (en) 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
JP7390728B2 (ja) * 2017-11-29 2023-12-04 バグワークス・リサーチ・インコーポレイテッド 抗菌複素環式化合物及びそれらの合成
UA127629C2 (uk) 2018-08-13 2023-11-08 Ф. Хоффманн-Ля Рош Аг Нові гетероциклічні сполуки як інгібітори моноацилгліцеролліпази
MX2022002311A (es) 2019-09-12 2022-03-25 Hoffmann La Roche Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de monoacilglicerol lipasa (magl).
WO2021190727A1 (en) * 2020-03-24 2021-09-30 F. Hoffmann-La Roche Ag Compounds and their use in the treatment of bacterial infection
CN115785718B (zh) * 2022-11-25 2023-08-22 四川大学 一种多基底表面的金属配位抗菌涂层及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297042A1 (de) 1987-06-23 1988-12-28 Ciba-Geigy Ag Substituierte Penem-Verbindungen
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
WO2001030782A2 (en) 1999-10-29 2001-05-03 Syngenta Participations Ag Novel herbicides
EP1448538A1 (en) 2001-11-15 2004-08-25 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
US20090186834A1 (en) 2005-03-24 2009-07-23 Microbia, Inc. Diphenylheterocycle cholesterol absorption inhibitors
TW200734311A (en) 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
WO2008120655A1 (ja) 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. I型11βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CA2710087C (en) 2007-12-20 2015-06-02 Pharma Mar, S.A. Antitumoral compounds
US8349828B2 (en) 2008-02-20 2013-01-08 Actelion Pharmaceuticals Ltd. Azatricyclic antibiotic compounds
EP2254887B9 (en) 2008-02-22 2013-05-29 Actelion Pharmaceuticals Ltd. Oxazolidinone derivatives
MX2011000968A (es) * 2008-08-04 2011-03-02 Actelion Pharmaceuticals Ltd Derivados de alquilaminometiloxazolidinona triciclicos.
AR073774A1 (es) 2008-10-07 2010-12-01 Actelion Pharmaceuticals Ltd Compuestos antibioticos oxazolidinona triciclicos
EP2346862B1 (en) * 2008-10-10 2012-09-12 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
MX344529B (es) 2011-11-08 2016-12-19 Actelion Pharmaceuticals Ltd Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo.

Similar Documents

Publication Publication Date Title
JP2016516805A5 (cg-RX-API-DMAC7.html)
RU2501799C2 (ru) Поизводные оксазолидинона
IL283539B1 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
JP2010523645A5 (cg-RX-API-DMAC7.html)
HRP20230143T1 (hr) Nove kemijske molekule koje inhibiraju mehanizam prekrajanja za liječenje bolesti koje su posljedica defekata prekrajanja
JP2015514794A5 (cg-RX-API-DMAC7.html)
US20150057271A1 (en) Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
JP2012522007A5 (cg-RX-API-DMAC7.html)
RU2012126083A (ru) Производные аминооксазина
JP2019528291A5 (cg-RX-API-DMAC7.html)
JP2013542937A5 (cg-RX-API-DMAC7.html)
TWI825079B (zh) 新穎的芳基或雜芳基三唑酮衍生物或其鹽或包含彼等之醫藥組合物
JP2016512558A5 (cg-RX-API-DMAC7.html)
RU2014108919A (ru) Хиназолин-2,4-дионовые производные
JP2014532626A5 (cg-RX-API-DMAC7.html)
JP2020503291A5 (cg-RX-API-DMAC7.html)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
JP2014532754A5 (cg-RX-API-DMAC7.html)
RU2008116828A (ru) Комбинированный метод терапии замещенными оксазолидинонами для профилактики и лечения нарушений церебрального местного кровообращения
JP2018507234A5 (cg-RX-API-DMAC7.html)
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
JP2020512401A5 (cg-RX-API-DMAC7.html)
RU2015128025A (ru) Ингибиторы сомт
JP2018508553A5 (cg-RX-API-DMAC7.html)